Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 12,638 | 2,250 | 9,769 | 9,071 | 8,356 |
| Operating Income | -12,638 | -2,250 | -9,769 | -9,071 | -8,356 |
| Other Income | -2 | 1 | 23 | 429 | 255 |
| Pre-tax Income | -12,640 | -2,249 | -9,746 | -8,642 | -8,101 |
| Net Income Continuous | -12,640 | -2,249 | -9,746 | -8,642 | -8,101 |
| Net Income | $-12,640 | $-2,249 | $-9,746 | $-8,642 | $-8,101 |
| EPS Basic Total Ops | -4.40 | -0.80 | -4.00 | -3.60 | -4.40 |
| EPS Basic Continuous Ops | -4.55 | -0.83 | -3.95 | -3.52 | -4.34 |
| EPS Diluted Total Ops | -4.40 | -0.80 | -4.00 | -3.60 | -4.40 |
| EPS Diluted Continuous Ops | -4.55 | -0.83 | -3.95 | -3.52 | -4.34 |
| EBITDA(a) | $-12,179 | $-1,809 | $-9,547 | $-8,372 | $-8,084 |